generalized arterial calcification of infancy | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

538,300 results for “generalized arterial calcification of infancy”

Trials

View all 489740 →

Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)

48 participants · First posted Mar 27, 2018

Natural History of GACI With or Without ARHR2 or PXE

80 participants · First posted Nov 29, 2018

Active, not recruiting

The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency

27 participants · First posted Sep 21, 2023

Drugs

View all 4492 →

C5 inhibitor (oral, generalized myasthenia gravis)

agonist antibody (pulmonary arterial hypertension)

PDE10 inhibitors (Pulmonary Arterial Hypertension)

Organizations

View all 3289 →

National Bank of Canada

United Kingdom

Canadian Imperial Bank of Commerce

FACULTY OF MEDICINE, UNIVERSITY OF KELANIYA

Sri Lanka

News

View all 40779 →

Inozyme's INZ-701 Shows Promise in ENPP1 and ABCC6 Deficiencies

BioMarin's BMN 401 Shows Mixed Results in Phase 3 Trial for Rare ENPP1 Deficiency

Inozyme's INZ-701 Shows Promise in ENPP1 Deficiency Trial with Sustained Phosphate Increases

Page 1 of 53830